Items where Author is "Moghadam, Ebrahim Rahmani"

Article

Ashrafizadeh, Milad and Zarrabi, Ali and Hushmandi, Kiavash and Hashemi, Farid and Moghadam, Ebrahim Rahmani and Owrang, Marzieh and Hashemi, Fardin and Makvandi, Pooyan and Goharrizi, Mohammad Ali Sheikh Beig and Najafi, Masoud and Khan, Haroon (2021) Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: role of microRNAs and upstream mediators. Cellular Signalling, 78 . ISSN 0898-6568 (Print) 1873-3913 (Online)

Ashrafizadeh, Milad and Zarrabi, Ali and Hushmandi, Kiavash and Moghadam, Ebrahim Rahmani and Hashemi, Farid and Daneshi, Salman and Hashemi, Fardin and Tavakol, Shima and Mohammadinejad, Reza and Najafi, Masoud and Dudha, Namrata and Garg, Manoj (2021) C-myc signaling pathway in treatment and prevention of brain tumors. Current Cancer Drug Targets, 21 (1). pp. 2-20. ISSN 1568-0096 (Print) 1873-5576 (Online)

Ashrafizadeh, Milad and Zarrabi, Ali and Hushmandi, Kiavash and Zarrin, Vahideh and Moghadam, Ebrahim Rahmani and Hashemi, Farid and Makvandi, Pooyan and Samarghandian, Saeed and Khan, Haroon and Hashemi, Fardin and Najafi, Masoud and Mirzaei, Hamed (2020) Toward regulatory effects of curcumin on transforming growth factor-beta across different diseases: a review. Frontiers in Pharmacology, 11 . ISSN 1663-9812

Ashrafizadeh, Milad and Taeb, Shahram and Hushmandi, Kiavash and Orouei, Sima and Shahinozzaman, Md and Zabolian, Amirhossein and Moghadam, Ebrahim Rahmani and Raei, Mehdi and Zarrabi, Ali and Khan, Haroon and Najafi, Masoud (2020) Cancer and SOX proteins: new insight into their role in ovarian cancer progression/inhibition. Pharmacological Research, 161 . ISSN 1043-6618 (Print) 1096-1186 (Online)

Moghadam, Ebrahim Rahmani and Ang, Hui Li and Asnaf, Sholeh Etehad and Zabolian, Amirhossein and Saleki, Hossein and Yavari, Mohammad and Esmaeili, Hossein and Zarrabi, Ali and Ashrafizadeh, Milad and Kumar, Alan Prem (2020) Broad-spectrum preclinical antitumor activity of chrysin: current trends and future perspectives. Biomolecules, 10 (10). ISSN 2218-273X

Ashrafizadeh, Milad and Zarrabi, Ali and Hashemi, Farid and Moghadam, Ebrahim Rahmani and Hashemi, Fardin and Entezari, Maliheh and Hushmandi, Kiavash and Mohammadinejad, Reza and Najafi, Masoud (2020) Curcumin in cancer therapy: a novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sciences, 256 . ISSN 0024-3205 (Print) 1879-0631 (Online)

Ashrafizadeh, Milad and Zarrabi, Ali and Hushmandi, Kiavash and Zarrin, Vahideh and Moghadam, Ebrahim Rahmani and Zabolian, Amirhossein and Tavakol, Shima and Samarghandian, Saeed and Najafi, Masoud (2020) PD-1/PD-L1 axis regulation in cancer therapy: the role of long non-coding RNAs and microRNAs. Life Sciences, 256 . ISSN 0024-3205 (Print) 1879-0631 (Online)

Ashrafizadeh, Milad and Hushmandi, Kiavash and Moghadam, Ebrahim Rahmani and Zarrin, Vahideh and Kashani, Sharareh Hosseinzadeh and Bokaie, Saied and Najafi, Masoud and Tavakol, Shima and Mohammadinejad, Reza and Nabavi, Noushin and Hsieh, Chia Ling and Zarepour, Atefeh and Zare, Ehsan Nazarzadeh and Zarrabi, Ali and Makvandi, Pooyan (2020) Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer. Bioengineering, 7 (3). ISSN 2306-5354

Ashrafizadeh, Milad and Najafi, Masoud and Ang, Hui Li and Moghadam, Ebrahim Rahmani and Mahabady, Mahmood Khaksary and Zabolian, Amirhossein and Jafaripour, Leila and Bejandi, Atefe Kazemzade and Hushmandi, Kiavash and Saleki, Hossein and Zarrabi, Ali and Kumar, Alan Prem (2020) PTEN, a barrier for proliferation and metastasis of gastric cancer cells: from molecular pathways to targeting and regulation. Biomedicines, 8 (8). ISSN 2227-9059

Ashrafizadeh, Milad and Ang, Hui Li and Moghadam, Ebrahim Rahmani and Mohammadi, Shima and Zarrin, Vahideh and Hushmandi, Kiavash and Samarghandian, Saeed and Zarrabi, Ali and Najafi, Masoud and Mohammadinejad, Reza and Kumar, Alan Prem (2020) MicroRNAs and their influence on the zeb family: mechanistic aspects and therapeutic applications in cancer therapy. Biomolecules, 10 (7). ISSN 2218-273X

Ashrafizadeh, Milad and Zarrabi, Ali and Orouei, Sima and Zarrin, Vahideh and Moghadam, Ebrahim Rahmani and Zabolian, Amirhossein and Mohammadi, Shima and Hushmandi, Kiavash and Gharehaghajlou, Yashar and Makvandi, Pooyan and Najafi, Masoud and Mohammadinejad, Reza (2020) STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects. Biology, 9 (6). ISSN 2079-7737

Ashrafizadeh, Milad and Zarrabi, Ali and Saberifar, Sedigheh and Hashemi, Farid and Hushmandi, Kiavash and Hashemi, Fardin and Moghadam, Ebrahim Rahmani and Mohammadinejad, Reza and Najafi, Masoud and Garg, Manoj (2020) Nobiletin in cancer therapy: how this plant derived-natural compound targets various oncogene and onco-suppressor pathways. Biomedicines, 8 (5). ISSN 2227-9059